MODULATION OF DIACYLGLYCEROL ACYLTRANSFERASE 2 EXPRESSION
    67.
    发明申请
    MODULATION OF DIACYLGLYCEROL ACYLTRANSFERASE 2 EXPRESSION 有权
    二乙酰胆碱酯酶2的表达调控

    公开(公告)号:US20130123331A1

    公开(公告)日:2013-05-16

    申请号:US13566674

    申请日:2012-08-03

    IPC分类号: C12N15/113

    摘要: Compounds, compositions and methods are provided for modulating the expression of diacylglycerol acyltransferase 2. The compositions comprise oligonucleotides, targeted to nucleic acid encoding diacylglycerol acyltransferase 2. Methods of using these compounds for modulation of diacylglycerol acyltransferase 2 expression and for diagnosis and treatment of diseases and conditions associated with expression of diacylglycerol acyltransferase 2 are provided.

    摘要翻译: 提供化合物,组合物和方法用于调节二酰基甘油酰基转移酶2的表达。该组合物包含靶向编码二酰基甘油酰基转移酶的核酸的寡核苷酸2.使用这些化合物调节二酰基甘油酰基转移酶2表达并用于诊断和治疗疾病的方法 提供了与二酰基甘油酰基转移酶2的表达相关的病症。

    Compositions and their uses directed to PTPRU
    69.
    发明授权
    Compositions and their uses directed to PTPRU 有权
    组合及其针对PTPRU的用途

    公开(公告)号:US08202981B2

    公开(公告)日:2012-06-19

    申请号:US13009626

    申请日:2011-01-19

    IPC分类号: C07H21/04 C07H21/02 A61K48/00

    摘要: Disclosed herein are compounds, compositions and methods for modulating the expression of PTPRU in a cell, tissue or animal. Also provided are methods of active target segment validation. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders. Also provided are methods for the prevention, amelioration and/or treatment of diabetes, obesity, insulin resistance, insulin deficiency, hypercholesterolemia, hyperglycemia, hyperlipidemia, hypertriglyceridemia, hyperfattyacidemia, liver steatosis, steatohepatitis, non-alcoholic steatohepatitis, metabolic syndrome, cardiovascular disease and coronary heart disease by administration of antisense compounds targeted to PTPRU.

    摘要翻译: 本文公开了用于调节细胞,组织或动物中PTPRU表达的化合物,组合物和方法。 还提供了主动目标段验证的方法。 还提供了所公开的化合物和组合物在制备用于治疗疾病和病症的药物中的用途。 还提供了用于预防,改善和/或治疗糖尿病,肥胖症,胰岛素抵抗,胰岛素缺乏,高胆固醇血症,高血糖症,高脂血症,高甘油三酯血症,高脂肪肝,肝脂肪变性,脂肪性肝炎,非酒精性脂肪性肝炎,代谢综合征,心血管疾病和 通过给予针对PTPRU的反义化合物的冠心病。